1-20 of 61
cognitive impairment
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S49–S67
DOI: https://doi.org/10.2337/dc23-S004
Published: 12 December 2022
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
Journal Articles

Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Bo Liang, Ning Gu
Journal: Diabetes Care
Diabetes Care 2022;45(10):e150
DOI: https://doi.org/10.2337/dc22-0778
Published: 19 September 2022
View article titled, Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251
Click here to open pdf in another window PDF for Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251
Journal Articles

Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Gaetano Santulli, Salvatore Frullone, Maria Morgante, Gaetano Macina, Antonella Pansini, Jessica Gambardella, Angela Lombardi, Pasquale Mone
Journal: Diabetes Care
Diabetes Care 2022;45(10):e151–e152
DOI: https://doi.org/10.2337/dci22-0025
Published: 19 September 2022
View article titled, Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251
Click here to open pdf in another window PDF for Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251
Journal Articles

Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Pasquale Mone, Angela Lombardi, Jessica Gambardella, Antonella Pansini, Gaetano Macina, Maria Morgante, Salvatore Frullone, Gaetano Santulli
Journal: Diabetes Care
Diabetes Care 2022;45(5):1247–1251
DOI: https://doi.org/10.2337/dc21-2434
Published: 14 March 2022
View article titled, Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Click here to open pdf in another window PDF for Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Journal Articles

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

Haiyan Cheng, Zhou Zhang, Bing Zhang, Wen Zhang, Jin Wang, Wenyu Ni, Yingwen Miao, Jiani Liu, Yan Bi
Journal: Diabetes Care
Diabetes Care 2022;45(5):1201–1210
DOI: https://doi.org/10.2337/dc21-2064
Published: 09 March 2022
View article titled, Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study
Click here to open pdf in another window PDF for Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee
Journal: Diabetes Care
Diabetes Care 2022;45(Supplement_1):S46–S59
DOI: https://doi.org/10.2337/dc22-S004
Published: 16 December 2021
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
Journal Articles

Response to Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Katherine Samaras, John D. Crawford, Brian Draper, Julian N. Trollor, Henry Brodaty, Perminder S. Sachdev
Journal: Diabetes Care
Diabetes Care 2021;44(4):e74
DOI: https://doi.org/10.2337/dci20-0077
Published: 15 March 2021
View article titled, Response to Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701
Click here to open pdf in another window PDF for Response to Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701
Journal Articles

Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Jorge Rafael Violante-Cumpa, Luis Alberto Pérez-Arredondo, José Gerardo González-González, Leonardo Guadalupe Mancillas-Adame
Journal: Diabetes Care
Diabetes Care 2021;44(4):e73
DOI: https://doi.org/10.2337/dc20-2881
Published: 15 March 2021
View article titled, Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701
Click here to open pdf in another window PDF for Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701
Journal Articles

Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes

Laili Soleimani, Ramit Ravona-Springer, Hung-Mo Lin, Xiaoyu Liu, Mary Sano, Anthony Heymann, Michal Schnaider Beeri
Journal: Diabetes Care
Diabetes Care 2021;44(3):655–662
DOI: https://doi.org/10.2337/dc20-2031
Published: 19 January 2021
View article titled, Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes
Click here to open pdf in another window PDF for Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2021;44(Supplement_1):S40–S52
DOI: https://doi.org/10.2337/dc21-S004
Published: 04 December 2020
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2020;43(Supplement_1):S37–S47
DOI: https://doi.org/10.2337/dc20-S004
Published: 16 December 2019
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020
Journal Articles

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Bernard Zinman, Julio Rosenstock, Jyothis T. George, Anna Passera, Sven Schnaidt, Odd Erik Johansen
Journal: Diabetes Care
Diabetes Care 2019;42(10):1930–1938
DOI: https://doi.org/10.2337/dc19-0783
Published: 09 August 2019
View article titled, Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
Click here to open pdf in another window PDF for Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
Includes: Supplementary data
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2019;42(Supplement_1):S34–S45
DOI: https://doi.org/10.2337/dc19-S004
Published: 07 December 2018
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019
Journal Articles

Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial

Tali Cukierman-Yaffe, Jackie Bosch, Hyejung Jung, Zubin Punthakee, Hertzel C. Gerstein
Journal: Diabetes Care
Diabetes Care 2019;42(1):142–147
DOI: https://doi.org/10.2337/dc18-0690
Published: 13 November 2018
View article titled, Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial
Click here to open pdf in another window PDF for Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial
Includes: Supplementary data
Journal Articles

3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2018

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2018;41(Supplement_1):S28–S37
DOI: https://doi.org/10.2337/dc18-S003
Published: 24 November 2017
View article titled, 3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2018
Click here to open pdf in another window PDF for 3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2018
Journal Articles

Index

Journal: Diabetes Care
Diabetes Care 2018;41(Supplement_1):S156–S159
DOI: https://doi.org/10.2337/dc18-in01
Published: 24 November 2017
View article titled, Index
Click here to open pdf in another window PDF for Index
Journal Articles

In This Issue of Diabetes Care

Journal: Diabetes Care
Diabetes Care 2017;40(11):1423–1424
DOI: https://doi.org/10.2337/dc17-ti11
Published: 12 October 2017
View article titled, In This Issue of Diabetes Care
Click here to open pdf in another window PDF for In This Issue of Diabetes Care
Journal Articles

Comment on Ekblad et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Erfan Ayubi, Saeid Safiri
Journal: Diabetes Care
Diabetes Care 2017;40(9):e135
DOI: https://doi.org/10.2337/dc17-0876
Published: 14 August 2017
View article titled, Comment on Ekblad et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758
Click here to open pdf in another window PDF for Comment on Ekblad et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758
Journal Articles

Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Laura L. Ekblad, Juha O. Rinne, Pauli Puukka, Hanna Laine, Satu Ahtiluoto, Raimo Sulkava, Matti Viitanen, Antti Jula
Journal: Diabetes Care
Diabetes Care 2017;40(9):e136
DOI: https://doi.org/10.2337/dci17-0023
Published: 14 August 2017
View article titled, Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758
Click here to open pdf in another window PDF for Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758
Journal Articles

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline

Andreea M. Rawlings, A. Richey Sharrett, Thomas H. Mosley, Shoshana H. Ballew, Jennifer A. Deal, Elizabeth Selvin
Journal: Diabetes Care
Diabetes Care 2017;40(7):879–886
DOI: https://doi.org/10.2337/dc16-2203
Published: 13 June 2017
View article titled, Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline
Click here to open pdf in another window PDF for Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline
Includes: Supplementary data